News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
236,106 Results
Type
Article (31940)
Company Profile (39)
Press Release (204127)
Multimedia
Podcasts (129)
Webinars (9)
Section
Business (67652)
Career Advice (1815)
Deals (13207)
Drug Delivery (127)
Drug Development (34366)
Employer Resources (194)
FDA (7623)
Job Trends (6763)
News (123209)
Policy (15139)
Tag
Academia (1652)
Accelerated approval (5)
Adcomms (29)
Allergies (40)
Alliances (19418)
ALS (39)
Alzheimer's disease (821)
Antibody-drug conjugate (ADC) (114)
Approvals (7546)
Artificial intelligence (136)
Autoimmune disease (19)
Automation (8)
Bankruptcy (144)
Best Places to Work (5288)
BIOSECURE Act (22)
Biosimilars (105)
Biotechnology (32)
Bladder cancer (40)
Brain cancer (17)
Breast cancer (139)
Cancer (1102)
Cardiovascular disease (134)
Career advice (1526)
Career pathing (33)
CAR-T (98)
Cell therapy (235)
Cervical cancer (10)
Clinical research (26903)
Collaboration (394)
Company closure (1)
Compensation (76)
Complete response letters (25)
COVID-19 (2372)
CRISPR (21)
C-suite (89)
Cystic fibrosis (57)
Data (887)
Decentralized trials (2)
Denatured (45)
Depression (35)
Diabetes (162)
Diagnostics (2545)
Digital health (9)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (60)
Drug pricing (125)
Drug shortages (32)
Duchenne muscular dystrophy (60)
Earnings (25859)
Editorial (45)
Employer branding (25)
Employer resources (163)
Events (27600)
Executive appointments (246)
FDA (8184)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (4)
Funding (310)
Gene editing (56)
Generative AI (18)
Gene therapy (237)
GLP-1 (731)
Government (3625)
Grass and pollen (3)
Guidances (44)
Healthcare (7745)
Huntington's disease (23)
IgA nephropathy (21)
Immunology and inflammation (119)
Indications (15)
Infectious disease (2472)
Inflammatory bowel disease (94)
Inflation Reduction Act (11)
Influenza (30)
Intellectual property (35)
Interviews (352)
IPO (5405)
IRA (51)
Job creations (1589)
Job search strategy (1236)
Kidney cancer (9)
Labor market (42)
Layoffs (516)
Leadership (24)
Legal (2923)
Liver cancer (43)
Lung cancer (176)
Lymphoma (79)
Machine learning (4)
Management (64)
Manufacturing (237)
MASH (47)
Medical device (5115)
Medtech (5116)
Mergers & acquisitions (8011)
Metabolic disorders (562)
Multiple sclerosis (53)
NASH (21)
Neurodegenerative disease (79)
Neuropsychiatric disorders (32)
Neuroscience (1150)
NextGen: Class of 2025 (2855)
Non-profit (2187)
Now hiring (40)
Obesity (358)
Opinion (242)
Ovarian cancer (33)
Pain (41)
Pancreatic cancer (36)
Parkinson's disease (68)
Partnered (13)
Patents (105)
Patient recruitment (20)
Peanut (19)
People (17210)
Pharmaceutical (11)
Pharmacy benefit managers (21)
Phase I (7561)
Phase II (11453)
Phase III (10911)
Pipeline (690)
Policy (171)
Postmarket research (1120)
Preclinical (2788)
Press Release (18)
Prostate cancer (54)
Psychedelics (35)
Radiopharmaceuticals (156)
Rare diseases (280)
Real estate (2384)
Recruiting (73)
Regulatory (10084)
Reports (45)
Research institute (1313)
Resumes & cover letters (282)
Rett syndrome (4)
RNA editing (4)
RSV (41)
Schizophrenia (53)
Series A (66)
Series B (31)
Service/supplier (4)
Sickle cell disease (32)
Special edition (18)
Spinal muscular atrophy (85)
Sponsored (34)
Startups (1456)
Stomach cancer (15)
Supply chain (64)
Tariffs (46)
The Weekly (82)
Vaccines (700)
Venture capitalists (39)
Weight loss (291)
Women's health (28)
Worklife (20)
Date
Today (53)
Last 7 days (343)
Last 30 days (1025)
Last 365 days (13004)
2025 (4261)
2024 (14080)
2023 (16056)
2022 (22061)
2021 (22809)
2020 (22148)
2019 (19027)
2018 (15315)
2017 (11492)
2016 (10728)
2015 (11601)
2014 (8360)
2013 (6727)
2012 (7271)
2011 (7483)
2010 (6641)
Location
Africa (498)
Alabama (17)
Alaska (2)
Arizona (50)
Arkansas (4)
Asia (14791)
Australia (2499)
California (2067)
Canada (682)
China (186)
Colorado (81)
Connecticut (120)
Delaware (56)
Europe (35494)
Florida (332)
Georgia (63)
Idaho (22)
Illinois (208)
India (20)
Indiana (162)
Iowa (5)
Japan (90)
Kansas (47)
Kentucky (8)
Louisiana (7)
Maine (36)
Maryland (480)
Massachusetts (1471)
Michigan (64)
Minnesota (118)
Mississippi (1)
Missouri (32)
Montana (14)
Nebraska (7)
Nevada (37)
New Hampshire (36)
New Jersey (693)
New Mexico (6)
New York (687)
North Carolina (300)
North Dakota (1)
Northern California (920)
Ohio (84)
Oklahoma (5)
Oregon (17)
Pennsylvania (436)
Puerto Rico (4)
Rhode Island (13)
South America (643)
South Carolina (7)
South Dakota (1)
Southern California (774)
Tennessee (34)
Texas (271)
United States (8084)
Utah (40)
Virginia (42)
Washington D.C. (33)
Washington State (187)
West Virginia (1)
Wisconsin (35)
236,106 Results for "gi supply".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GI Alliance and Iterative Health Partner to Advance GI Clinical Research in the Community
April 23, 2025
·
3 min read
Press Releases
I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025
April 30, 2025
·
4 min read
Press Releases
GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy
January 23, 2025
·
2 min read
Press Releases
Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health’s Crofelemer to be Presented at April 2025 ELITE PED-GI Congress
April 18, 2025
·
7 min read
Press Releases
Natera to Present New Data at the 2025 ASCO GI Symposium
January 21, 2025
·
8 min read
Press Releases
Palisade Bio Announces Two Abstracts Selected to be Showcased as Poster of Distinction and Poster Presentation at Leading GI Forum, Digestive Disease Week (DDW) 2025
March 12, 2025
·
4 min read
Manufacturing
Viking Secures 1B Supply of Obesity Pill Candidate With $150M Prepayment Deal
Analysts acknowledged the long-term manufacturing deal could dull Viking’s takeout prospects but hailed it as a smart move to ensure supply.
March 11, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
RenovoRx Highlights Promising Pharmacokinetic Data Abstract Presented at ASCO GI 2025
January 27, 2025
·
11 min read
Cancer
BMS, Pfizer Challenge Colorectal Cancer Standard Care With ASCO GI Readouts
Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that could position them as new standards of care in certain subtypes of metastatic colorectal cancer.
January 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentation at ASCO GI 2025
January 9, 2025
·
2 min read
1 of 23,611
Next
